Is Sermorelin FDA Approved?
Sermorelin was FDA-approved in the past, but not in the way many online ads suggest. The FDA approved a brand product called Geref (sermorelin acetate) on September 26, 1997. That product is now listed as discontinued, so no FDA-approved sermorelin product is currently sold in the United States.
Shop Medications
This article walks through what the FDA record says, what “discontinued” means, and how to read claims about sermorelin approval. It stays focused on approval status. Safety and purchasing are covered in separate guides on this site.
In This Article
- Is Sermorelin FDA Approved Right Now?
- When Did the FDA Approve Sermorelin, and What Was It Approved For?
- What Does It Mean That Geref Is Listed as Discontinued?
- Is Sermorelin the Same as Geref?
- Does an Orphan Drug Designation Mean Sermorelin Was Approved for Infertility?
- Is Compounded Sermorelin FDA Approved?
- Is Sermorelin FDA Approved for Aging or Wellness Use?
- How Can You Check the FDA Approval Status of Any Drug Yourself?
- What Should You Ask Your Doctor If Sermorelin Comes Up?
- References
Is Sermorelin FDA Approved Right Now?
No active FDA-approved sermorelin product is on the U.S. market today. Sermorelin acetate was approved under the brand name Geref, but the FDA database lists the Geref products as discontinued. The approval history remains in the record, while the product itself is no longer marketed.
So the honest answer has two parts. Sermorelin once had FDA approval. Today, a patient cannot get an FDA-approved sermorelin product from a pharmacy shelf. Any sermorelin offered now is a different kind of product, which we cover below.

Why Pay Full Price?
Search our full medication catalogue and save up to 80% - no insurance needed.
See Prices NowWhen Did the FDA Approve Sermorelin, and What Was It Approved For?
The FDA approved Geref (sermorelin acetate) on September 26, 1997, under application number NDA 020443. The original approval record concerns testing whether the pituitary gland can release growth hormone. It was not a broad approval for wellness or aging.
The pituitary is a small gland at the base of the brain. It makes growth hormone. In a diagnostic use, a doctor gives a drug and then checks whether the gland responds. That is a very narrow medical job.
A peer-reviewed paper on growth hormone-releasing hormone peptides also describes sermorelin, sold as Geref, as an FDA-approved peptide with a defined medical use. The same paper separates sermorelin from other similar peptides. The key point is that approval always comes with a specific use. It does not cover every use someone may want.
What Does It Mean That Geref Is Listed as Discontinued?
Discontinued means the product is no longer being sold under that approval. It does not erase the past approval. FDA databases keep a record of what was approved, and they mark the current marketing status separately. For Geref, that status reads discontinued.
The database listings show the status but do not explain the reason in the entry itself. It is best not to guess why a company stopped selling a product. Read the status for what it is: the approved product is not currently available.
Is Sermorelin the Same as Geref?
Sermorelin is the active ingredient, and Geref was the FDA-approved brand product that contained it. Sermorelin is a lab-made chain of 29 amino acids. It matches the front section of the body’s own growth hormone-releasing hormone.
Amino acids are the small building blocks of proteins and peptides. A peptide is a short chain of them. The same ingredient can appear in very different products. An FDA-approved brand has been reviewed as a finished product. A copy made elsewhere has not gone through that same review just because it shares the ingredient name.
This idea applies to other drugs too. For example, tesamorelin (Egrifta) is a related peptide that has its own separate FDA approval for a different purpose. Approval of one peptide does not carry over to another.
Does an Orphan Drug Designation Mean Sermorelin Was Approved for Infertility?
No. An orphan drug designation is not an approval. Sermorelin acetate once received an orphan designation tied to an infertility-related use, but the FDA record says that designation was withdrawn or revoked. It also states sermorelin was not FDA-approved for that use.
An orphan designation is a status the FDA gives to drugs aimed at rare conditions. It can come with incentives for the drug maker. It only says the drug is being studied for a rare condition. It does not say the drug works or is safe for that condition.
This is a common point of confusion. If a website mentions “FDA designation” or “FDA recognized,” check whether it means approval. Often it does not.
Is Compounded Sermorelin FDA Approved?
No. Compounded medicines are not FDA approved. A compounding pharmacy prepares a custom version of a drug for an individual patient, and the FDA does not review those products for safety, effectiveness, or quality before they are made. Compounded sermorelin therefore has no FDA approval of its own.
Compounding is a legal and common practice for some needs. But it is a separate pathway from FDA approval. When a clinic says its sermorelin is “FDA approved,” that claim usually mixes up two things: the old Geref approval and a newly prepared compounded product.
The accurate statement is that sermorelin acetate had an FDA-approved brand product in the past. The compounded version you may be offered today does not carry that approval. If you want to understand the risks of sermorelin itself, see our guide on whether sermorelin is safe. For buying rules, see our guide on whether you can buy sermorelin.
Is Sermorelin FDA Approved for Aging or Wellness Use?
No. The FDA record ties sermorelin’s approval history to a narrow diagnostic use, not to general aging, energy, or wellness goals. No FDA approval exists for sermorelin as an anti-aging treatment. Using it for those goals is considered off-label or unapproved use.
Off-label means a doctor uses a drug for a purpose the FDA has not approved. Doctors can sometimes do this when they judge it appropriate. But off-label use is not the same as approval, and it should not be described as approval.
Be careful with marketing words such as “clinically proven” or “FDA-backed.” These phrases sound official but do not tell you whether the FDA approved a product for the use being advertised.
How Can You Check the FDA Approval Status of Any Drug Yourself?
Search the active ingredient in the FDA’s Drugs@FDA database, then read the approval history and marketing status. You can also check the FDA Orange Book, which lists approved products and whether each is active or discontinued. Both are free, official, and updated by the FDA.
Here is a simple way to check:
- Search the drug name or active ingredient, such as sermorelin acetate.
- Open the application record and note the approval date.
- Read the marketing status. Look for words like prescription, over the counter, or discontinued.
- Check the approved use. Make sure it matches what the seller says the product does.
For sermorelin, this check shows a September 26, 1997 approval for Geref and a discontinued status. It takes only a few minutes and cuts through most misleading claims.
What Should You Ask Your Doctor If Sermorelin Comes Up?
Ask what the product is, who makes it, and whether it is FDA-approved or compounded. Then ask what condition it is meant to treat and what evidence supports that use. A good clinician can answer these questions clearly and will not hide behind vague wording.
You can also ask about other options. Some growth hormone-related conditions have FDA-approved treatments that go through full review. Your doctor can tell you whether testing or treatment makes sense for your situation.
In short, sermorelin has a real but limited approval history. It was FDA-approved as Geref; that product is now discontinued, and compounded versions are not FDA-approved. Knowing this helps you separate accurate information from marketing.
References
- Drugs@FDA: Geref (sermorelin acetate), NDA 020443. U.S. Food and Drug Administration. Accessed October 30, 2026.
- Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations, Geref (sermorelin acetate). U.S. Food and Drug Administration. Accessed October 30, 2026.
- FDA list of approved drug products: Geref, sermorelin acetate. U.S. Food and Drug Administration. Accessed October 30, 2026.
- Exploring FDA-Approved Frontiers: Insights into Natural and Synthetic Growth Hormone-Releasing Hormone Peptides. National Institutes of Health, PubMed Central. 2024. Accessed October 30, 2026.
- Sermorelin. National Institutes of Health, PubChem. Accessed October 30, 2026.
- FDA Orphan Drug Designations and Approvals: Sermorelin acetate. U.S. Food and Drug Administration. Accessed October 30, 2026.